Incidence and Course of Joint Inflammation Associated with Inflammatory Bowel Disease in Patients Undergoing Treatment with Vedolizumab/Ustekinumab: The VEDUSTAR Study by Irene Gonzalez Diaz, Mariana Gutierrez Riart, Maria Dolores Martin-Arranz, Chamaida Plasencia Rodriguez, Cristina Suarez Ferrer, on behalf of VEDUSTAR Research Team

Get full text